Prism Medico & Pharmacy Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 1.59 | 0.08 | 0.21 |
Operating Expense | 0.94 | 0.06 | 0.22 |
Net Profit | 0.66 | 0.04 | -0.01 |
Net Profit Margin | 41.51 | 50 | -4.76 |
Earning Per Share | 0.01 | TBA | TBA |
EBIDTA | 0.66 | 0.04 | -0.01 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Jun 2025 |
---|---|
Revenue | 1.59 |
Operating Expense | 0.94 |
Net Profit | 0.66 |
Net Profit Margin | 41.51 |
Earning Per Share | 0.01 |
EBIDTA | 0.66 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 0.63 | 2.93 | 1.27 |
Operating Expenses Annual | 0.71 | 3.06 | 1.37 |
Operating Profit Annual | -0.06 | -0.02 | -0.10 |
Interest Annual | 0.00 | 0.01 | 0.00 |
Depreciation | 0.00 | 0.01 | 0.01 |
Net Profit Annual | -0.05 | -0.02 | -0.08 |
Tax Annual | -0.02 | -0.01 | -0.03 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 0.63 |
Operating Expenses Annual | 0.71 |
Operating Profit Annual | -0.06 |
Interest Annual | 0.00 |
Depreciation | 0.00 |
Net Profit Annual | -0.05 |
Tax Annual | -0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.08 | 0.10 | 0.06 |
Cash Flow from Operations | -0.02 | -0.01 | 2.95 |
Cash Flow from Investing | TBA | TBA | -2.91 |
Cash Flow from Financing | TBA | -0.01 | TBA |
Cash Flow at the End | 0.07 | 0.08 | 0.10 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.08 |
Cash Flow from Operations | -0.02 |
Cash Flow from Investing | TBA |
Cash Flow from Financing | TBA |
Cash Flow at the End | 0.07 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | -9.52 | -0.34 | -7.87 |
PBIT Margin (%) | -9.52 | -0.68 | -8.66 |
PBT Margin (%) | -9.52 | 67.58 | -8.66 |
Net PROFIT Margin (%) | -7.94 | -0.68 | -6.30 |
Return On Networth / Equity (%) | -0.33 | -0.13 | -0.58 |
Return On Networth /Employed (%) | -0.46 | -0.13 | -0.79 |
Return On Assets (%) | -0.32 | -0.13 | -0.57 |
Total Debt / Equity (X) | TBA | TBA | TBA |
Asset Turnover Ratio (%) | 0.04 | 0.19 | 0.09 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | -9.52 |
PBIT Margin (%) | -9.52 |
PBT Margin (%) | -9.52 |
Net PROFIT Margin (%) | -7.94 |
Return On Networth / Equity (%) | -0.33 |
Return On Networth /Employed (%) | -0.46 |
Return On Assets (%) | -0.32 |
Total Debt / Equity (X) | TBA |
Asset Turnover Ratio (%) | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 0.03 | 0.03 | 0.03 |
Total Current Assets Annual | 15.30 | 14.99 | 15.15 |
Non Current Assets Annual | 0.27 | 0.25 | 0.25 |
Total Shareholders Funds Annual | 15.09 | 15.14 | 15.16 |
Total Assets Annual | 15.56 | 15.24 | 15.39 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 0.03 |
Total Current Assets Annual | 15.30 |
Non Current Assets Annual | 0.27 |
Total Shareholders Funds Annual | 15.09 |
Total Assets Annual | 15.56 |
EPS (INR)
Expected
0.00
Reported
-0.07
Surprise
0.00%
Sep 2019
EPS beaten by 0.00%
Jun 2019
EPS beaten by 0.00%
Mar 2019
EPS beaten by 0.00%